as on October 31, 2025 at 8:32 pm IST
Day's Low

5.00%
Downside
52 Week's Low
52 Week's High

13.30%
Downside
433.33%
Upside

Check Virax Biolabs Group Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$2.6M
EPS (TTM)
-1.48
Dividend Yield
0.00%
PE Ratio (TTM)
0PEG Ratio
0Return On Equity TTM
-114.47%
Compare market cap, revenue, PE, and other key metrics of Virax Biolabs Group Ltd with its industry peers.
| Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | 
|---|---|---|---|---|---|
| NA | $2.6M | NA | NA | 0.00% | |
| BUY | $41.1B | 489.62% | -16.34 | -259.82% | |
| BUY | $63.1B | 265.59% | -505.15 | -12.96% | |
| BUY | $107.0B | 101.52% | 29.67 | 31.86% | |
| BUY | $68.6B | 20.33% | 15.65 | 32.13% | 
The Virax Biolabs Group Ltd stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Virax Biolabs Group Ltd investment value today
Current value as on today
₹34,627
Returns
Returns from Virax Biolabs Group Ltd Stock
Dollar Returns*
₹5,642 (+5.64%)
Search interest for Virax Biolabs Group Ltd Stock has increased by 11% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:11% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
 NO EFFECT
NO EFFECTAgainst Peers

In the last 3 years, Insmed Incorporated has given 1021.4% return, outperforming this stock by 1117.5%
 NO EFFECT
NO EFFECTAgainst Peers

In the last 1 year, Insmed Incorporated has given 188.7% return, outperforming this stock by 260.1%
 NEGATIVE IMPACT
NEGATIVE IMPACTRevenue Fall

Revenue is down for the last 3 quarters, 79.91K → 1.37K (in $), with an average decrease of 83.0% per quarter
 NEGATIVE IMPACT
NEGATIVE IMPACTPrice Dip

In the last 3 months, VRAX stock has moved down by -26.8%
 NEGATIVE IMPACT
NEGATIVE IMPACTProfit Down

Netprofit is down for the last 2 quarters, -2.75M → -3.30M (in $), with an average decrease of 19.9% per quarter
| Organisation | Virax Biolabs Group Ltd | 
| Headquarters | BioCity Glasgow, Lanarkshire, United Kingdom, ML1 5UH | 
| CEO | Mr. James Foster | 
| E-voting on shares | Click here to vote | 
| Name | Title | 
|---|---|
| Mr. James Foster | Chairman, CEO & Principal Accounting Officer | 
| Dr. Nigel McCracken M.Sc., Ph.D. | COO & Director | 
| Mr. Clement Monteil | Head of Scientific Research & Development | 
| Ms. Lily Fu | Head of Supply Chain | 
Virax Biolabs Group Ltd share price today is $0.6 as on . Virax Biolabs Group Ltd share today touched a day high of $0.6 and a low of $0.57.
Virax Biolabs Group Ltd share touched a 52 week high of $3.2 on and a 52 week low of $0.52 on . Virax Biolabs Group Ltd stock price today i.e. is trending at $0.6,which is 81.25% down from its 52 week high and 15.34% up from its 52 week low.
Virax Biolabs Group Ltd market capitalisation is $0.00T as on .
Indian investors can start investing in Virax Biolabs Group Ltd (VRAX) shares with as little as ₹88.665 or $1 (as of ) using the INDmoney app. 
      
      For example: If you want to invest $10 or ₹886.65 in Virax Biolabs Group Ltd stock (as per the Rupee-Dollar exchange rate as on ). 
        Based on Virax Biolabs Group Ltd share’s latest price of $0.6 as on October 31, 2025 at 8:32 pm IST, you will get 16.6667 shares of Virax Biolabs Group Ltd. Learn more about
          
            fractional shares .